| __timestamp | Verona Pharma plc | Viatris Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4101058 | 581800000 |
| Thursday, January 1, 2015 | 10763215 | 671900000 |
| Friday, January 1, 2016 | 5579049 | 876700000 |
| Sunday, January 1, 2017 | 32051299 | 857900000 |
| Monday, January 1, 2018 | 24482286 | 822200000 |
| Tuesday, January 1, 2019 | 43892589 | 778200000 |
| Wednesday, January 1, 2020 | 44505000 | 512600000 |
| Friday, January 1, 2021 | 79406000 | 681000000 |
| Saturday, January 1, 2022 | 49283000 | 662200000 |
| Sunday, January 1, 2023 | 17282730 | 910700000 |
Unleashing insights
In the competitive world of pharmaceuticals, innovation is key. Viatris Inc. and Verona Pharma plc, two prominent players, have shown distinct approaches to research and development (R&D) over the past decade. From 2014 to 2023, Viatris consistently outpaced Verona Pharma in R&D spending, investing nearly 25 times more on average. In 2023, Viatris allocated a staggering 910 million dollars, marking a 56% increase from its 2014 expenditure. Meanwhile, Verona Pharma's investment peaked in 2021 at approximately 79 million dollars, a significant rise from its 2014 figure, but still a fraction of Viatris's commitment. This disparity highlights Viatris's aggressive strategy to lead in pharmaceutical innovation, while Verona Pharma adopts a more conservative approach. As the industry evolves, these investment patterns may shape the future landscape of drug development and market leadership.
R&D Insights: How Eli Lilly and Company and Verona Pharma plc Allocate Funds
Comparing Innovation Spending: Incyte Corporation and Viatris Inc.
Research and Development Investment: Viatris Inc. vs Corcept Therapeutics Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and ADMA Biologics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and ACADIA Pharmaceuticals Inc.
Comparing Innovation Spending: Viatris Inc. and HUTCHMED (China) Limited
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and Supernus Pharmaceuticals, Inc.
Viatris Inc. or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?
Ascendis Pharma A/S vs Verona Pharma plc: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Verona Pharma plc vs CRISPR Therapeutics AG
Research and Development: Comparing Key Metrics for Verona Pharma plc and Catalyst Pharmaceuticals, Inc.
Analyzing R&D Budgets: Verona Pharma plc vs Travere Therapeutics, Inc.